Pharmafile Logo
Pharmafocus logo
Advanced Search

stroke

Showing 15 posts of 28 posts found.

American Heart Association awards $2.1m to research link between migraine, strokes and CVD

July 27, 2023
Research and Development American Heart Association, Cardiology, cvd, migraine, stroke

The American Heart Association has announced that it will fund seven new scientific research studies to learn more about the …

News
milad-fakurian-58z17lnvs4u-unsplash_2

NHS given guidance on offering genetic testing to stroke patients

May 19, 2023
Medical Communications NHS, Neurology, blood clot, genetic testing, stroke

The NHS has been given draft guidance on offering gene tests to patients who have had a stroke caused by …

News
36745826313_86e4ffa6ac_b

New Johnson & Johnson study aiming to add stroke detection to Apple Watch

February 26, 2020
Research and Development Apple, Janssen, Johnson & Johnson, apple watch, iphone, stroke

Johnson & Johnson announced that Janssen Pharmaceuticals will work in collaboration with Apple to explore apps for stroke detection. It …

News
boehringer_biberach_germany_copy

Boehringer’s Pradaxa fails to meet Phase 3 endpoint in preventing recurrent stroke

May 20, 2019
Research and Development, Sales and Marketing Boehringer, Pradaxa, pharma, stroke, trial failure

Boehringer has announced that Pradaxa (dabigatran etexilate mesylate) has failed to meet its primary endpoint in its Phase 3 study, …

News
blood-1813410_960_720

Heart drugs show promise in stroke and dementia

April 25, 2019
Research and Development angina, cilostazol, dementia, heart drugs, isosorbide mononitrate, stroke

Drugs for heart disease and angina have shown promise as preventative treatments for stroke and dementia, according to scientists from …

News
amgen_flag

China’s NMPA approves Amgen’s Repatha to reduce cardiovascular event risk

January 25, 2019
Medical Communications, Sales and Marketing Amgen, China, Repatha, cardiovascular disease, pharma, stroke

Amgen has announced that its proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor Repatha (evolocumab) has secured approval by China’s drug …

News
biogen_idec_hillerod_2008

Biogen halts Tysabri trial after failure in acute ischemic stroke

February 8, 2018
Research and Development Biogen, Tysabri, multiple sclerosis, pharma, stroke, trial failure

Biogen has halted its investigation into the efficacy of its humanised monoclonal antibody Tysabri (natalizumab) in the treatment of acute …

News
stroke

Incidence of strokes in younger people rising

February 1, 2018
Medical Communications biotech, drugs, pharma, pharmaceutical, stroke

On the day that a new campaign for greater awareness of stroke symptoms has been released, new figures show that …

News
heart-2338154_960_720

12% of the UK have hearts ten years older than they are, Public Health England finds

September 4, 2017
Research and Development, Sales and Marketing British Heart Foundation, Public Health England, cardiovascular disease, heart attack, heart health, stroke

New findings from Public Health England (PHE)’s Heart Age Test indicate that around 10% of men in the UK are …

News
reneuron

ReNeuron’s stem cell therapy improves motor function in stroke study

December 5, 2016
Research and Development ReNeuron, stem cell, stem cell therapy, stroke

ReNeuron, a UK-based biotechnology company, posted results of its experimental stem cell therapy for patients who had been disabled after …

News
merck_and_co

MSD drops osteoporosis trial drug due to stroke risk

September 5, 2016
Research and Development, Sales and Marketing MSD, Merck, Odanacatib, osteoporosis, stroke

MSD, known as Merck in the US and Canada, has announced that it has finally decided to discontinue the development …

News
brilinta

AstraZeneca’s Brilinta fails to best aspirin in treating stroke patients

March 23, 2016
Research and Development AstraZeneca, Brilinta, stroke

AstraZeneca has announced top-line results from the Phase III SOCRATES trial, confirming that twice-daily doses of its drug Brilinta (ticagrelor) failed …

News
flu_vaccien_smaller

Flu jab reduces risk of stroke for two months

October 6, 2015
Research and Development flu vaccine, stroke

The risk of suffering a stroke is significantly reduced for up to two months after receiving a flu vaccine, a …

News
Bayer image

Bayer launches major new stroke trial

January 27, 2015
Research and Development, Sales and Marketing Bayer, Canadian Stroke Prevention Intervention Network, Population Health Research Institute, Xarelto, rivaroxaban, stroke

Bayer is enrolling more than 7,000 people in a trial to test whether its blood-thinning drug Xarelto can successfully prevent …

News

Lundbeck scraps stroke drug

December 18, 2014
Research and Development, Sales and Marketing AIS, DIAS, Lundbeck, acute ischemic stroke, desmoteplase, stroke

Lundbeck has stopped development of its investigational stroke drug desmoteplase following disappointing results from its Phase III studies. The DIAS-3 …

News

Latest content

EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment

April 22, 2024

Neurolentech and Kaerus Bioscience enter partnership for research on neurodevelopmental disorder

April 22, 2024

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024